KAIROS PHARMA, LTD. (KAPA)
Kairos Pharma Recaps Important Acquisitions and Details Plans for the Balance of 2026 in Letter to Shareholders
Kairos Pharma Recaps Important Acquisitions and Details Plans for the Balance of 2026 in Letter to Shareholders
PepsiCo Announces Timing and Availability of Second-Quarter 2026 Financial Results
Natera and CytoDyn Announce Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer
IMUNON Announces Up to $10 Million Cash Financing
Alight to appoint Finance Industry Veteran Stephen A. Lasher as Chief Financial Officer
DevvStream Announces $6 Million Equity Investment from EEME Energy; Gives Notice to Terminate $300 Million Equity Line of Credit
New Leidos SATCOM tool boosts combat connectivity, effectiveness
Aptiv’s Winchester Interconnect Launches VITA 67.2 RF Connector Product Line for High-Density Aerospace and Defense Systems
Evolv Technology and Philadelphia Phillies Expand Partnership with Multi-Year Renewal of Evolv Express®
Visa and Brale Explore Private Stablecoin Settlement for Institutional Payments